BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6333269)

  • 21. Lysis of autologous tumor cells by high-density lymphocytes is potentiated by the streptococcal preparation OK432 (Picibanil).
    Vánky F; Uchida A; Klein E; Willems J
    Int J Cancer; 1986 Apr; 37(4):531-6. PubMed ID: 3082771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tumor infiltrating T lymphocyte components in malignant pleural effusion of lung adenocarcinoma and their killing activities to autologous tumor cells].
    Xia Z; Liu J; Qing B; Wang W; Chen M; Yuan Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Oct; 44(10):1107-1112. PubMed ID: 31857503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients.
    Chen YM; Yang WK; Ting CC; Tsai WY; Yang DM; Whang-Peng J; Perng RP
    Chest; 1997 Oct; 112(4):960-6. PubMed ID: 9377959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Induction of activated natural killer cells by the streptococcal preparation OK432 (I). Induction from spleen cells of normal or tumor-bearing mouse primed in vivo and subsequently challenged in vitro with OK432].
    Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
    Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1370-8. PubMed ID: 2809371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysis of lymphoma cells by cultured large granular lymphocytes.
    Oshimi K; Oshimi Y; Naohara T; Mizoguchi H
    Exp Hematol; 1985 Dec; 13(11):1192-6. PubMed ID: 3877647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-alpha in serum and carcinomatous pleural effusion after repeated intrapleural injections of antitumor agents.
    Kaneto E; Sasaki H; Tamura I; Kurimura O; Kurimura T
    Biken J; 1983 Jun; 26(2):99-102. PubMed ID: 6318725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural cytotoxicity of lymphocytes and monocytes and its augmentation by OK432 in melanoma patients.
    Yanagawa E; Uchida A; Kokoschka EM; Micksche M
    Cancer Immunol Immunother; 1984; 16(3):131-6. PubMed ID: 6200209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of K562 lysis in autologous LGL and dense T cell cocultures.
    Tsukuda K; Piontek GE; Lewin N; Jondal M; Klein E
    Immunol Lett; 1985; 9(5):291-5. PubMed ID: 3158601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer.
    Ishida A; Miyazawa T; Miyazu Y; Iwamoto Y; Zaima M; Kanoh K; Sumiyoshi H; Doi M
    Respirology; 2006 Jan; 11(1):90-7. PubMed ID: 16423208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The streptococcal preparation OK-432 specifically augments the susceptibility of human urinary bladder tumor cells to autologous peripheral blood lymphocytes.
    Mizutani Y; Nio Y; Yoshida O
    Cancer; 1992 Jun; 69(12):2999-3007. PubMed ID: 1591693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intrapleural transfer of LAK cells combined with rIL-2 in the treatment of advanced lung cancer with malignant pleural effusion].
    Li DJ
    Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):294-6. PubMed ID: 2625114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation by the protein-bound polysaccharide PSK (krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer.
    Mizutani Y; Yoshida O
    J Urol; 1991 May; 145(5):1082-7. PubMed ID: 2016797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
    Uchida A; Klein E
    Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infiltration of interleukin-2-inducible killer cells in ascitic fluid and pleural effusions of advanced cancer patients.
    Blanchard DK; Kavanagh JJ; Sinkovics JG; Cavanagh D; Hewitt SM; Djeu JY
    Cancer Res; 1988 Nov; 48(22):6321-7. PubMed ID: 2972357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Augmentation of cytotoxicity of tumor infiltrating lymphocytes by interleukin-2 in gastric cancer patients].
    Gotoh K
    Nihon Geka Gakkai Zasshi; 1985 Dec; 86(12):1600-7. PubMed ID: 3878935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lysing of fresh human tumor by a cytotoxic factor derived from autologous large granular lymphocytes independently of other known cytokines.
    Uchida A; Fujimoto T; Mizutani Y
    Cancer Immunol Immunother; 1990; 31(1):60-4. PubMed ID: 2106392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of NK cell cytotoxic factor against fresh human tumors.
    Uchida A; Fukata H
    Nat Immun; 1993; 12(4-5):267-78. PubMed ID: 8257831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous mixed lymphocyte-tumor reaction and autologous mixed lymphocyte reaction. I. Proliferation of two distinct T-cell subsets.
    Uchida A; Moore M; Klein E
    Int J Cancer; 1987 Aug; 40(2):165-70. PubMed ID: 2956198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Killing of tumor cells with pleiotropic drug resistance by OK432-activated effector cells.
    Allavena P; Peccatori F; Maggioni D; Pirovano P; Mantovani A
    Immunopharmacol Immunotoxicol; 1989; 11(2-3):257-68. PubMed ID: 2621319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Locoregional immunotherapy of malignant effusion from colorectal cancer using the streptococcal preparation OK-432 plus interleukin-2: induction of autologous tumor-reactive CD4+ Th1 killer lymphocytes.
    Yamaguchi Y; Miyahara E; Ohshita A; Kawabuchi Y; Ohta K; Shimizu K; Minami K; Hihara J; Sawamura A; Toge T
    Br J Cancer; 2003 Nov; 89(10):1876-84. PubMed ID: 14612896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.